Potent in Vitro and In Vivo Efficacy of BYON4413, a Duba-Based Antibody-Drug Conjugate Targeting CD123 in Acute Myeloid Leukemia

被引：3
|
作者：
van der Lee, Miranda [1 ]
van Achtenberg, Tanja [1 ]
Brouwers-Vos, Annet [2 ]
van der Vleuten, Monique [1 ]
Kappers, Wendy [1 ]
Verheijden, Gijs [1 ]
Huls, Geert A. [3 ]
van Wigcheren, Glenn [1 ]
Ubink, Ruud [1 ]
Sesink, Aloys [1 ]
MacInnes, Alyson [1 ]
Schuringa, Jan Jacob [4 ]
Dokter, Wim [1 ]
机构：
[1] Byondis BV, Nijmegen, Netherlands
[2] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands
[3] Univ Med Ctr Groningen, Groningen, Netherlands
[4] Univ Med Ctr Groningen, Dept Expt Hematol, Groningen, Netherlands
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-177622
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Synergistic Anti-Leukemic Activity of PARP Inhibition Combined with IMGN632, an Anti-CD123 Antibody-Drug Conjugate in Acute Myeloid Leukemia Models
    Fritz, Claire
    Portwood, Scott M.
    Adams, Julie
    Cronin, Tara
    Lutgen-Dunckley, Linda
    Martens, Brandon L.
    Sloss, Callum M.
    Watkins, Krystal
    Kovtun, Yelena
    Adams, Sharlene
    Wang, Eunice S.
    BLOOD, 2018, 132
  • [32] Antileukemia Efficacy and Mechanisms of Action of SL-101, a Novel Anti-CD123 Antibody Conjugate, in Acute Myeloid Leukemia
    Han, Lina
    Jorgensen, Jeffrey L.
    Brooks, Chris
    Shi, Ce
    Zhang, Qi
    Gonzalez, Graciela M. Nogueras
    Cavazos, Antonio
    Pan, Rongqing
    Mu, Hong
    Wang, Sa A.
    Zhou, Jin
    Al-Atrash, Gheath
    Ciurea, Stefan O.
    Rettig, Mike
    DiPersio, John F.
    Cortes, Jorge
    Huang, Xuelin
    Kantarjian, Hagop M.
    Andreeff, Michael
    Ravandi, Farhad
    Konopleva, Marina
    CLINICAL CANCER RESEARCH, 2017, 23 (13) : 3385 - 3395
  • [33] A novel human single-domain antibody-drug conjugate targeting CEACAM5 exhibits potent in vitro and in vivo antitumor activity
    Zhu, Xiao-yi
    Li, Quan-xiao
    Kong, Yu
    Huang, Ke-ke
    Wang, Gang
    Wang, Yun-ji
    Lu, Jun
    Hua, Guo-qiang
    Wu, Yan-ling
    Ying, Tian-lei
    ACTA PHARMACOLOGICA SINICA, 2024, 45 (03) : 609 - 618
  • [34] A novel human single-domain antibody-drug conjugate targeting CEACAM5 exhibits potent in vitro and in vivo antitumor activity
    Xiao-yi Zhu
    Quan-xiao Li
    Yu Kong
    Ke-ke Huang
    Gang Wang
    Yun-ji Wang
    Jun Lu
    Guo-qiang Hua
    Yan-ling Wu
    Tian-lei Ying
    Acta Pharmacologica Sinica, 2024, 45 : 609 - 618
  • [35] The Antibody-Drug Conjugate (ADC) IMGN779 Is Highly Active in Vitro and in Vivo Against Acute Myeloid Leukemia (AML) with FLT3-ITD Mutations
    Whiteman, Kathleen R.
    Noordhuis, Paul
    Walker, Russell
    Watkins, Krystal
    Kovtun, Yelena
    Harvey, Lauren
    Wilhelm, Alan
    Johnson, Holly
    Schuurhuis, Gerrit Jan
    Ossenkoppele, Gert J.
    Lutz, Robert J.
    BLOOD, 2014, 124 (21)
  • [36] Allogeneic TCRai3-deficient CAR T -cells targeting CD123 effectively eliminate myeloid leukemia cells in vitro and in vivo PDX mice
    Guzman, Monica L.
    Zong, Hongliang
    Sugita, Mayumi
    Lara-Martinez, Luis A.
    Bystrom, Laura M.
    Cruz, Nicole M.
    Galetto, Roman
    Gouble, Agnes
    Lebuhotel, Celine
    Bank, Alexander
    Smith, Julianne
    Roboz, Gail J.
    CANCER RESEARCH, 2016, 76
  • [37] Pediatric preclinical testing consortium evaluation of the CD123 antibody drug conjugate, IMGN632, against xenograft models of pediatric acute lymphoblastic leukemia
    Evans, Kathryn
    El-Zein, Narimanne
    Jones, Connor
    Erickson, Stephen W.
    Guo, Yuelong
    Teicher, Beverly A.
    Adams, Sharlene
    Zweidler-McKay, Patrick A.
    Smith, Malcolm A.
    Lock, Richard B.
    CANCER RESEARCH, 2019, 79 (13)
  • [38] CLT030, a leukemic stem cell-targeting CLL1 antibody-drug conjugate for treatment of acute myeloid leukemia
    Jiang, Ying-Ping
    Liu, Bob Y.
    Zheng, Quan
    Panuganti, Swapna
    Chen, Ruoying
    Zhu, Jianyu
    Mishra, Madhavi
    Huang, Jianqing
    Dao-Pick, Trang
    Roy, Sharmili
    Zhao, XiaoXian
    Lin, Jeffrey
    Banik, Gautam
    Hsi, Eric D.
    Mandalam, Ramkumar
    Junutula, Jagath R.
    BLOOD ADVANCES, 2018, 2 (14) : 1738 - 1749
  • [39] INA03: A Potent Transferrin-Competitive Antibody-Drug Conjugate against CD71 for Safer Acute Leukemia Treatment
    Bratti, Manuela
    Stubbs, Elisa
    Kolodych, Sergii
    Souchet, Herve
    Kelly, Lois
    Merlin, Johanna
    Marchal, Michelle
    Castellano, Remy
    Josselin, Emmanuelle
    Pasquer, Helene
    Benajiba, Lina
    Puissant, Alexandre
    Koniev, Oleksandr
    Collette, Yves
    Belanger, Coralie
    Hermine, Olivier
    Monteiro, Renato C.
    Launay, Pierre
    MOLECULAR CANCER THERAPEUTICS, 2024, 23 (08) : 1159 - 1175
  • [40] Maturing Clinical Profile of IMGN779, a Next-Generation CD33-Targeting Antibody-Drug Conjugate, in Patients with Relapsed or Refractory Acute Myeloid Leukemia
    Cortes, Jorge E.
    DeAngelo, Daniel J.
    Erba, Harry P.
    Traer, Elie
    Papadantonakis, Nikolaos
    Arana-Yi, Cecilia
    Blum, William
    Sloss, Callum M.
    Culm-Merdek, Kerry
    Zweidler-McKay, Patrick A.
    Wang, Eunice S.
    BLOOD, 2018, 132
12345